Filing Flows › Picard Medical (PMI) › Q2 2026 › vs Q2 2025
Picard Medical (PMI) Q2 2026 vs Q2 2025 (year over year)
Picard Medical's revenue rose $823K (+39%) from $2.1M in Q2 2025 to $3.0M in Q2 2026. The biggest changes: Product +$804K (+38%); Rentals +$19K (—).
Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%, net loss $5.7M, operating cash flow −$1.4M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product | $2.9M | $2.1M | $804K | +38% |
| Rentals | $19K | $0 | $19K | — |
| Revenue | $3.0M | $2.1M | $823K | +39% |
| Net loss | $5.7M | $6.7M | −$1.1M | -16% |
| Costs & expenses | $8.6M | $8.9M | −$241K | -3% |
| Operating costs | $7.6M | $5.7M | $1.9M | +34% |
| Interest & other, net | $1.0M | $3.2M | −$2.2M | -68% |
| Income tax | $7K | $0 | $7K | — |
| Cost of revenue | $2.3M | $2.3M | $80K | +4% |
| Research & development | $1.4M | $743K | $631K | +85% |
| SG&A | $3.9M | $2.7M | $1.2M | +46% |
| Operating cash sources | $5.7M | $6.7M | −$1.1M | -16% |
| Depreciation & amortization | $45K | $40K | $5K | +12% |
| Share-based compensation | $1.4M | $183K | $1.2M | +654% |
| Working capital & other | $2.9M | $4.0M | −$1.1M | -27% |
| Cash used in operations | $1.4M | $2.5M | −$1.2M | -47% |
| Net loss absorbed | $5.7M | $6.7M | −$1.1M | -16% |
Questions
How much did Picard Medical's revenue grow year over year in Q2 2026?
Picard Medical's revenue rose $823K (+39%) from $2.1M in Q2 2025 to $3.0M in Q2 2026.
What drove Picard Medical's revenue change in Q2 2026?
Product +$804K (+38%); Rentals +$19K (—).